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Abstract: Introduction: Better measures of liver transplant risk
stratiﬁcation are needed. Our previous work noted a strong relationship
between psoas muscle area and survival following liver transplantation.
The dorsal muscle group is easier to measure, but it is unclear if they are
also correlated with surgical outcomes.
Methods: Our study population included liver transplant recipients with
a preoperative CT scan. Cross-sectional areas of the dorsal muscle group
at the T12 vertebral level were measured. The primary outcomes for this
study were one- and ﬁve-yr mortality and one-yr complications. The
relationship between dorsal muscle group area and post-transplantation
outcome was assessed using univariate and multivariate techniques.
Results: Dorsal muscle group area measurements were strongly
associated with psoas area (r = 0.72; p < 0.001). Postoperative outcome
was observed from 325 patients. Multivariate logistic regression revealed
dorsal muscle group area to be a signiﬁcant predictor of one-yr mortality
(odds ratio [OR] = 0.53, p = 0.001), ﬁve-yr mortality (OR = 0.53,
p < 0.001), and one-yr complications (OR = 0.67, p = 0.007).
Conclusion: Larger dorsal muscle group muscle size is associated with
improved post-transplantation outcomes. The muscle is easier to measure
and may represent a clinically relevant postoperative risk factor.
Christopher S. Leea,b, David C.
Crona,b, Michael N. Terjimaniana,b,
Leah D. Canvassera,b, Alyssa A.
Mazureka,b, Ellen Vonfoerstera,b,
Lindsay M. Tishbergc, Patrick
W. Underwooda,b, Eric T. Changa,b,
Stewart C. Wanga,b, Christopher
J. Sonnendaya,b and Michael
J. Englesbea,b
aMorphomic Analysis Group, University of
Michigan, bDepartment of Surgery, University
of Michigan, Ann Arbor, MI and cSchool of
Medicine, Tufts University, Medford, MA, USA
Key words: dorsal muscle group – end-stage
liver disease – liver transplant – morphometric
measure – psoas muscle – risk stratification –
sarcopenia – surgical outcome
Corresponding author: Christopher S. Lee, 823
E Summerfield Glen CIR, Ann Arbor, MI,
48176, USA.
Tel.: +734 660 1504
Fax: 734-936-5725
e-mail: cleeho@med.umich.edu
Conflict of interest: None.
Accepted for publication 13 July 2014
Measuring disease severity for patients with end-
stage liver disease (ESLD) is a continuous challenge
for liver transplant surgeons, and there is a critical
need for better methods of risk stratiﬁcation. Cur-
rently, the liver allocation system emphasizes a
“sickest-ﬁrst” priority (1). Surgeons rely on a subjec-
tive assessment of a patient’s global health status – a
method often referred to as the “eyeball test” (2).
This judgment is subjective and neither robust nor
reliable. In contrast, preoperative imaging can pro-
vide objective measures of overall disease burden.
Pretransplant cross-sectional imaging holds vast
amount of patient-speciﬁc data that can aid in
prognostication. Within this context, our previous
work has shown that using analytic morphomic
techniques can provide important information
regarding postoperative outcomes. Trunk muscle
size – speciﬁcally the psoas muscle – is an objective
measure of surgical risk in multiple surgical spe-
cialties (3–7). However, measurement of the psoas
muscle is only available on abdominal scans. The
central location of the psoas muscle makes ultra-
sound imaging diﬃcult, hindering prospective and
repeated data collection. Alternatively, dorsal mus-
cle group is easier to obtain on both CT and ultra-
sound imaging and may facilitate prospective
studies on sarcopenia.
In this retrospective manuscript, we investigate
the relationship between dorsal muscle group
cross-sectional area and postliver transplantation
outcomes at a single institution. We hypothesize
that larger dorsal muscle cross-sectional area will
be correlated with larger psoas area and associated
with improved surgical outcomes. Overall, this
study investigates the utility of dorsal muscle
group size as a clinically relevant postoperative risk
factor and the potential alternative to measures of
psoas area. Investigation of these measures may
improve our understanding of the mechanisms of
liver disease and sarcopenia.
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Methods
Study population
Our study cohort included adult (≥18 yr old)
patients who underwent liver transplantation at the
University of Michigan Transplant Center between
2000 and 2011. Ninety-d perioperative CT scans
were collected, and eligible scans had available dor-
sal muscle group and psoas muscle measurements.
Recipient age, race, gender, BMI, preoperative
serum albumin, MELD score, hepatitis C virus
(HCV) positivity, presence of hepatocellular carci-
noma (HCC), presence of diabetes, presence of
hypertension, pack years of smoking, and donor
age were retrospectively collected for all patients.
Analytic morphomics
Dorsal muscle group area is deﬁned as any muscle
contained within the region posterior to the spine
and ribs, and no more lateral than the lateral-most
edges of the erector spinae muscles. CT scans were
processed by the following steps using semi-
automated algorithms in MATLAB v13.0 (Math-
Works, Natick, MA, USA). Initially, scans were
labeled at each vertebral level to provide anatomi-
cal landmarks for subsequent measurements.
Next, a posterior muscle line was drawn on
abdominal and thoracic slices separating muscle
from subcutaneous fat. Points were placed at the
lateral-most clefts of the erector spinae muscle. An
area was mapped out between these points, the
central point of the spinal canal, and the posterior
muscle line. Within this region, dorsal muscle
group size was calculated based on density thresh-
olds. Our primary measurement was the dorsal
muscle group cross-sectional area at the T12 verte-
bral level, which is more commonly present in
both thoracic and abdominal scans. Total psoas
area was also measured as described in our previ-
ous work (5). This entailed using a transverse slice
of L4 to outline the psoas muscles. This cross-sec-
tional area was computed as the total psoas area.
Fig. 1 illustrates these analytic morphomics
techniques.
Outcomes
Primary outcomes were deﬁned as overall post-
transplant survival, one-yr post-transplant mortality,
and ﬁve-yr post-transplant mortality. Patient death
was determined using the Social Security Death
Master Index. Additional outcomes included post-
operative complications within one yr of liver trans-
plant. These one-yr complications were identiﬁed as
renal failure, sepsis, bacterial infection (abscess, peri-
tonitis, cholangitis), multiple organ system failure,
bleeding, bile leak, pneumonia, respiratory failure,
cardiac event (myocardial infarction, arrest, conges-
tive heart failure), biliary stricture, graft failure,
thrombosis, Clostridium diﬃcile infection, acute
rejection, and pulmonary embolus.
Data analysis
Descriptive statistics were computed for the study
cohort. Continuous variables were summarized by
mean, standard deviation, and histograms. Com-
parisons were made using a Student’s t-test. Cate-
gorical variables were summarized with frequency
tables and compared using Fisher’s exact test. The
relationship between dorsal muscle group and pso-
as muscle size was assessed using a Pearson corre-
lation.
The covariate-adjusted eﬀect of dorsal muscle
group cross-sectional area on overall post-trans-
plant survival was ascertained using the Cox
proportional hazards regression model. Patients
Fig. 1. Preoperative CT imaging was
used to measure psoas and dorsal
muscle group size. After identifying
individual vertebral levels, the imaging
slices at the inferior aspects of L4 and
T12 vertebrae were selected. The total
cross-sectional area of the psoas
muscles was measured at the L4 level;
dorsal muscle group area was measured
at the T12 vertebrae.
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began follow-up at the time of liver transplantation
and were censored at loss of follow-up or
subsequent transplantation. Logistic regression was
used to assess the covariate-adjusted eﬀect of dorsal
muscle group area on one-yr mortality, ﬁve-yr mor-
tality, and one-yr incidence of complications. For
the Cox and logistic models, backward stepwise
selection was used for model selection. For each
outcome, univariate regression was used to identify
potential predictors of outcome. Candidate predic-
tors (threshold p ≤ 0.25) from the univariate analy-
sis were then entered into their respective models,
and backward stepwise selection was used to pro-
duce the ﬁnal subset of adjustment covariates. Age
and gender were included in the models regardless
of statistical signiﬁcance. Initially, dorsal muscle
group area was the only morphometric factor
included in these models. Later, total psoas area
was substituted for dorsal muscle group area in
each model to enable comparisons between the two
measures. The predictive ability of each logistic
model was assessed using the area under the recei-
ver operating characteristic (AUROC). Patients
were grouped into gender-stratiﬁed tertiles of dorsal
muscle group area and total psoas area to facilitate
comparison between groups.
All analyses were performed using Stata 13.0
(StataCorp LP, College Station, TX, USA). A
two-sided signiﬁcance of a = 0.05 was used for all
analyses. This study was approved by the Univer-
sity of Michigan Institutional Review Board.
Results
A total of 325 met our inclusion criteria; 39.1% of
the cohort was female (n = 127), and the mean age
at transplant was 52.0  9.6 yr. Mean laboratory
MELD score at the time of transplantation was
18.3  7.7. Descriptive and clinical characteristics
for the study population are displayed in Table 1,
stratiﬁed by tertiles of dorsal muscle group area.
Compared to patients in the largest tertile of dorsal
muscle group area, patients in the smallest tertile
had a signiﬁcantly greater MELD score
(p = 0.034), greater BMI (p < 0.001), greater total
psoas area (p < 0.001), and were signiﬁcantly more
likely to have HCC (p = 0.002).
Dorsal muscle group area was normally distrib-
uted across the study cohort (Fig. 2). Further,
dorsal muscle group area was signiﬁcantly larger
(p < 0.001) in males compared to females (3.39 
1.04 1000 mm2 vs. 2.53  0.74 1000 mm2, respec-
tively). Linear regression demonstrated a strong
positive correlation between dorsal muscle group
size and total psoas area (r = 0.72, p < 0.001).
Fig. 3 presents this signiﬁcant correlation.
Overall survival
Cox regression revealed that covariate-adjusted
mortality decreased signiﬁcantly as dorsal muscle
group area increased (hazard ratio [HR] = 0.62 per
standard deviation increase in dorsal muscle group
area, 95% CI: 0.49–0.77, p < 0.001). Also included
in the model were age (hazard ratio [HR] = 1.02
per standard deviation increase in dorsal muscle
group area, 95% CI: 1.00–1.05, p = 0.050),
diabetes (hazard ratio [HR] = 1.80 per standard
deviation increase in dorsal muscle group area,
95% CI: 1.20–2.70, p = 0.004), HCV positivity
(hazard ratio [HR] = 2.00 per standard deviation
increase in dorsal muscle group area, 95% CI:
Table 1. Patient Characteristics of Study Population (n = 325) Stratified by Tertiles of Dorsal Muscle Group Area at T12
Mean  SD, or % (N)
Smallest tertile Middle tertile Largest tertile
p-value (Comparison between
largest and smallest tertile)
N 108 108 109
Age_at_txp 50.45  11.31 53.39  9.41 51.60  8.77 0.805
% Non-white 11.32% (12) 16.67% (18) 19.27% (21) 0.129
Dorsal_muscle (1000 mm2) 2.09  0.34 2.95  0.24 4.23  0.75 <0.001
Psoas (1000 mm2) 1.28  0.29 1.94  0.19 2.79  0.43 <0.001
BMI (kg/m2) 26.54  6.55 27.63  5.79 30.09  5.68 <0.001
Diabetes 25.93% (28) 28.70% (31) 30.09% (32) 0.648
Hypertension 43.52% (47) 51.85 (56) 50.93% (55) 0.336
Cirrhosis 43.52% (47) 38.89% (42) 38.53% (42) 0.578
Pack_years_smoking 9.94  16.43 14.33  19.07 12.50  16.82 0.257
HCC 27.78% (30) 40.74% (44) 48.62% (53) 0.002
HCV 14.81% (16) 29.63% (32) 41.28% (45) 0.578
MELD 19.25  7.98 18.50  7.68 17.01  7.27 0.034
Preoperative albumin 2.85  0.69 2.75  0.57 2.85  0.67 0.984
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1.34–2.98, p = 0.001), and female gender (hazard
ratio [HR] = 1.43 per standard deviation increase
in dorsal muscle group area, 95% CI: 0.96–2.13,
p = 0.075).
Fig. 4 shows the covariate-adjusted hazard
ratios for dorsal muscle group area across its
observed range. The reference dorsal muscle group
area (HR = 1) is 3.05 (1000 mm2), which is the
mean area, standardized by gender. According to
Fig. 4, the HR for a patient with dorsal muscle
group area = 4.07 (1000 mm2) was 0.62, indicating
that patients with dorsal muscle group area that is
one standard deviation above the mean have a
38% lower hazards of dying compared to the
mean.
One-yr mortality
Multivariate logistic regression was used with
one-yr mortality as the binary outcome. Dorsal
muscle group area was a signiﬁcant predictor of
outcome (odds ratio [OR] = 0.53 per standard
deviation increase in dorsal muscle group area,
95% CI: 0.36–0.78, p = 0.001). Other covariates in
the model included female gender (p = 0.046), age
at transplant (p = 0.014), preoperative serum
albumin (p = 0.035), and donor age (p = 0.083).
The AUROC for this model was 0.74. When total
psoas area was substituted for dorsal muscle group
using the same model, this measure was also a
signiﬁcant predictor of one-yr mortality (OR =
0.43 per standard deviation increase in psoas area,
95% CI: 0.30–0.62, p < 0.001). The AUROC for
this model was 0.77. Including both muscle mea-
surements in the same model had no signiﬁcant
eﬀect on predictive ability (AUROC = 0.75). The
covariates from these models were used to calcu-
late adjusted one-yr mortality rates. Fig. 5A dis-
plays these rates stratiﬁed by tertiles of dorsal
muscle group and psoas size. Patients with the
largest dorsal muscle group area had a 3.3-fold
lower one-yr mortality rate compared to patients
with the smallest muscle area (7.6% vs. 34.9%).
Similarly, patients with the largest psoas area had
a 3.9-fold lower one-yr mortality rate compared to
the group with the smallest psoas area (6.7% vs.
26.3%).
Five-yr mortality
Multivariate logistic regression demonstrated dor-
sal muscle group area as a signiﬁcant predictor of
ﬁve-yr mortality (odds ratio [OR] = 0.53 per
Fig. 2. Histogram of dorsal muscle group area at T12. The dis-
tribution was normally distributed among both genders. Male
dorsal muscle group area was signiﬁcantly greater than that of
females (p < 0.001).
Fig. 3. The relationship between total psoas area and dorsal
muscle group area demonstrates a strong, signiﬁcant associa-
tion, with psoas area increasing with dorsal muscle group area.
Fig. 4. Cox model shows the eﬀect of dorsal muscle group area
on mortality following liver transplantation, as quantiﬁed with
covariate-adjusted hazard ratios (HR). The reference dorsal
muscle group area (HR = 1) is 3.05 1000 mm2, which is the
mean area, standardized by gender. The hazard ratio for a
patient with dorsal muscle group area that is one standard
deviation larger than the mean area was HR = 0.617
(p < 0.001), indicating a 38% decrease in post-transplantation
mortality rate per standard deviation increase in muscle area.
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standard deviation increase in dorsal muscle
group area, 95% CI: 0.38–0.70, p < 0.001); also
signiﬁcant in the model were female gender
(p = 0.048), HCV positivity (p = 0.003), and dia-
betes (p = 0.026). Although transplant age was
not signiﬁcant (p = 0.145), it remained in the
model due to its clinical relevance. The AUROC
for this model was 0.70. When total psoas area
was substituted for dorsal muscle group area
using the same model, psoas area was a strong of
a predictor of one-yr mortality (odds ratio
[OR] = 0.43 per standard deviation increase in
psoas area, 95% CI: 0.30–0.62, p < 0.001). The
AUROC for this model was 0.71. Including both
muscle measurements in the same model had no
signiﬁcant eﬀect on predictive ability (AU-
ROC = 0.71). Fig. 5B displays covariate-adjusted
ﬁve-yr mortality rates stratiﬁed by dorsal muscle
group and psoas area. Patients with the largest
dorsal muscle group area had a 6.2-fold lower
ﬁve-yr mortality rate than the smallest group
(10% vs. 62.3%). Similarly, patients with the
largest psoas area had a 5.5-fold lower ﬁve-yr
mortality rate compared to those with the small-
est psoas area (10.5% vs. 57.7%).
Complications
Dorsal muscle group area was also a signiﬁcant
predictor of post-transplant complications within
one yr (odds ratio [OR] = 0.67 per increase in stan-
dard deviation of dorsal muscle group area, 95%
CI: 0.50–0.90, p = 0.007); also signiﬁcant in the
model were pack years (p = 0.025), HCC
(p = 0.001), and donor age (p = 0.045). Neither
transplant age (p = 0.719) nor female gender
(p = 0.144) were signiﬁcant, but both were kept in
the model. The AUROC for this model was 0.72.
Total psoas area was substituted for dorsal muscle
group area using the same model, revealing psoas
area to be a signiﬁcant predictor of one-yr compli-
cations (odds ratio [OR] = 0.48 per increase in
standard deviation of psoas area, 95% CI: 0.32–
0.72, p < 0.001). The AUROC for the psoas model
was 0.73. Including both muscle groups in the
model had no signiﬁcant eﬀect on its predictive
ability (AUROC = 0.74). Covariate-adjusted inci-
dence of one-yr complications was stratiﬁed into
tertiles of both dorsal muscle group and psoas
area. The group with the largest dorsal muscle
group area had a 1.3-fold lower complication rate
compared to the smallest group (69.8% vs.
90.3%). Similarly, patients with the largest psoas
area had a 1.4-fold lower one-yr adjusted compli-
cate rate than the group with the smallest psoas
area (66.1% vs. 90.5%).
Discussion
In this study, we demonstrate that dorsal muscle
group area is a signiﬁcant independent risk factor
in liver transplant recipients. We have demon-
strated that patients with larger dorsal muscle
group area have improved survival and fewer
complications post-transplantation. The correla-
tion between dorsal muscle group area and total
psoas area suggests that either of these core mus-
cles may serve as a measure of physiologic reserve
and a target for risk stratiﬁcation.
The predictive ability of morphometric assess-
ment is becoming more recognized in scientiﬁc
literature (3–9). Several studies have shown sarco-
penic patients having poorer outcomes when
compared to their peers, including in liver
Fig. 5. (A) One-yr postliver transplant mortality. The adjusted
one-yr mortality rate of the largest dorsal muscle area group
was 7.6% compared to 24.9% for the smallest, and was 6.7%
for the largest total psoas area group compared to 26.3% for
the smallest. (B) Five-yr postliver transplant mortality. The
adjusted ﬁve-yr mortality rate of the largest dorsal muscle area
group was 10.0% compared to 62.3% for the smallest, and was
10.5% for the largest total psoas area group compared to
57.7% for the smallest.
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transplantation (3, 10). While considered a facet of
aging, sarcopenia has also been identiﬁed as an
independent predictor of surgical outcome (2, 3, 6,
10–12). Sarcopenia is a major feature of ESLD;
liver dysfunction results in protein malnutrition,
which accelerates muscle loss in cirrhotic patients
(10, 11). Potentially, morphometric assessment can
help better understand the pathophysiology of
ESLD.
While total psoas area has been shown to be a
robust and reproducible measure of risk, there are
limitations to its utility. When measured, psoas
cross-sectional area was assessed at the L4 verte-
bral level. An important consideration in selecting
a morphometric measure is its location relative to
the area of pathology. As the L4 vertebra is
inferior to the liver, radiographic workups may not
always capture the region needed for adequate
psoas measurement. This study aims to contribute
to the existing body of literature by proposing a
potentially novel risk factor that is easier to obtain.
Dorsal muscle group measurements were taken at
the T12 vertebra, which is often included on both
thoracic and abdominal CT scans. In this context,
the dorsal muscle group’s proximity to the liver
makes it more likely to be included in patient
scans.
Considering the risks of CT imaging, ultrasound
imaging could serve as a safer alternative. Visibility
has made the psoas muscle diﬃcult to capture via
ultrasound. However, the dorsal muscle group
spans the entire length of the thorax and abdomen,
making them easier to image via ultrasound, which
could provide a prospective and dynamic assess-
ment of muscle size. Ultrasound measurements of
muscle size would have to be compared to that
of CT imaging to determine its utility as a measure
of risk stratiﬁcation. If dorsal muscle group area
was to prove measurable via ultrasound, this
method would be a fast, low-risk measure to assess
sarcopenia.
There are important limitations of this study.
This was a retrospective study and is subject to the
inherent biases of that approach. Although this is
a single-institution experience and cannot be repre-
sentative of a larger transplant population, we feel
that the methodology of this study validates the
introduction of a novel measure of risk stratiﬁca-
tion. Second, patients undergoing high-risk surgery
tend to have higher complication rates. Within this
context, liver transplant recipients are often more
frail due to disease severity, which in addition to
the physiological stresses of transplantation could
have a confounding eﬀect on the incidence of
complications.
In the future, morphometric assessment can
inform decisions regarding candidate appropriate-
ness as well as aid in the selection of patients for
pretransplant optimization programs. Potentially,
a further understanding of the mechanisms of liver
disease and sarcopenia could help in the design of
targeted interventions that delay functional
decline, which in speciﬁc cases have been associ-
ated with improved outcome (13, 14). Future stud-
ies can generalize our ﬁndings by investigating the
relationship regarding dorsal muscle group size,
patients without chronic illness, and outcomes of
other major surgical operations.
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